These usually happen when you first start treatment or increase your dose, as your body gets used to the medication
Experimental studies carried out during many years have revealed several biological mechanisms that deserve to be researched, such as angiogenesis, connective tissues, digestive system physiology, cell migration and signaling pathways
So there was this question of: Whats happening here
Comparative cytotoxic effects and possible mechanisms of deoxynivalenol, zearalenone and T-2 toxin exposure to porcine leydig cells in vitro
Computational cardiology technologies, comprehensive genetics, or the use of biomarkers may help to overcome this challenge
Anti-inflammatory peptides KPV and similar compounds for systemic inflammation reduction